Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
使用自体黑色素瘤细胞/树突状细胞疫苗在 I/II 期试验中获得持久完整的临床反应
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-003-0375-x
Michael G E O'Rourke, Maree Johnson, Catherine Lanagan, Janet See, Jie Yang, John R Bell, Greg J Slater, Beverley M Kerr, Beth Crowe, David M Purdie, Suzanne L Elliott, Kay A O Ellem, Christopher W Schmidt
